Association between polymorphisms of the androgen and vitamin D receptor genes  with prostate cancer risk in a Mexican population

Brenda Patino-Garcia; Carlos Arroyo; Hector Rangel-Villalobos; Elena Soto-Vega; Jose Salvador Velarde-Felix; Fernando Gabilondo; Ludla Sandoval-Ramirez; Luis Eduardo Figuera

2007, Number 1

Rev Invest Clin 2007; 59 (1)

Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population

Patino-Garcia B, Arroyo C, Rangel-Villalobos H, Soto-Vega E, Velarde-Felix JS, Gabilondo F, Sandoval-Ramirez L, Figuera LE

Full text

How to cite this article

Language: Spanish
References: 37
Page: 25-31
PDF size: 0. Kb.

ABSTRACT

No abstract

REFERENCES

1.Dirección General de Epidemiología Registro Histopatológico de Neoplasias Malignas,Cd 2004.www.dgepi.salud.gob.mx.
2.Hsing AW, Chokkalingam AP.Prostate cancer epidemiology.Front Biosci 2006: 1(11):1388-413.
3.Ko YJ,Devi GR,London CA,Kayas A,Reddy MT,et al.Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense: J Urol 2004: 172(3):1140-4.
4.Suzuki H,Shimbo M, Ichikawa T.New biomarkers for prostate cancer.Nippon Rinsho 2005;63(2): 351-9.
5.Hakimi JM,Schoenberg MP,Rondinelli RH,Piantadosi S,Barrack ER.Androgen receptor variants with short glutamine and glycine repeats may identify unique subpopulations of men with prostate cancer.Clin Cancer Res 1997;3:1599-608.
6.Hsing AW,Gao YT,Wu G,Wang X,Deng J,et al.Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk:a population-based case-control study in China.CANCER rES 2000;60: 5111-116.
7.Mowszowicz I,Mestaver C.Mutations of the androgen receptor gene a possible role in proatate cancer.Bull Cancer 1997;84(2): 183-8.
8.Lange EM,Chen H,Brierley K,Livermore H,Wojno KJ,et al.The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited prediposition to prostate cancer.Cancer Epidemiol Biomarkers Prev 2000;9:439-42.
9.Correa-Cerro L,Wohr G,Haussler J,Berthon P,Drelon E, er al.(CAG)CAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in French-German population.Eur J Hum Genet 1999;7: 357-62.
10.Tayed MT,Clark C, Haites NE,Sharp L, Murray GI,et al.Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with bening prostate hyperplasia.Saudi Med J 2004; 25(4):447-51.
11.Bid HK,Mishra DK,Mittal RD.Vitamind-D recepto(VDR)gene (Fok-1,Taq-1 and Apa-1)polymorphisms in healthy in individuals from north indian population.Asian Pac J Cancer Prev 2005; 6(2): 147-52.
12.Cheteri MB,Stanford JL,Friederichsen DM,Peters MA,Iwasaki L, et al.Vitamin D receptor gene polymorphisms and prostate cancer risk.Prostate 2004:59(4): 409-18.
13.Correa-Cerro L,Berthon P, Haussler J,Bochum S, Drelon E, et al. Vitamin D receptor polymorphisms as markers in prostate cancer.Hum Genet 1999; 105: 281-7.
14.Ntais C, Polycarpou A, loannidis JP.Vitamin D receptor gene polymorphisms and risk of prostate cancer:a meta-analysis.Cancer Epidemiol Biomarkers Prev 2003; 12(12): 1395-402.
15.Macoska J.Ancestry, genetic susceptibility, E/Caqdherin160A and prostate cancer risk-is there an association? J Urol 2006; 176(2): 435-6.
16.Chamberlain NL,Driver ED,Miesfeld RL.The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function.Nucleic Acids Res 1994; 2:3181-6.
17.Coerzee GA,Ross RK.Re:Prostate cancer and the androgen receptor.J Natl Cancer Inst 1994; 86:872-3.
18.Irvine RA,Ma H, Yu MC,Ross RK,Stallcup MR,et al Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine.Hum Genet 2000;9:267-74.
19.Nelson KA,White JS.Androgen receptor CAG repeats and prostate cancer.Am J Epidemiol 2002; 155:883-90.
20.Yoshida KI,Yano M, Chiba K,Honda Kitahara S.CAG repeat length in the androgen receptor gene is enhanced in patients with idiopathic azoospermia.Urology 1999;54:1078-81.
21.Zitzmann M,Brune M,Kornmann B,Gromoll J,Junker R, et al. The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males.Clin Endocrinol(Oxf)2001;55:649-57.
22.Sawaya ME,Shalita AR.Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia,hirsutim,and acne.J Cutan Med Surg 1998; 3: 9-15.
23.Giovannucci E, Stampfer MJ,Chan A,Krithivas K, Gann PH,et al. CAG repeat within the androgen receptor gene and incidence of surgery for bening prostatic hyperplasia in U.S.physicians.Prostate 1999;39:130-4.
24.Giovannucci E,Platz EA,Stampfer MJ,Chan A,Krithivas K, et al.The CAG repeat within the androgen receptor gene and bening prostatic hyperplasia(BPH):CORRELATION WITH adenoma growth.Prostate 1999;41:121-5
25.Mitsumori K,Terai A,Oka H,Segawa T,Ogura K,et al.Androgen redeptor CAG repeat length polymorphism in bening prostatic hyperplasia(BPH):CORRELATION WITH adenoma growth.Prostate 1994;41:253-57.
26.Shibata A,Stamey TA McNeal JE,Cheng I,Peehl DM.Genetic polymorphisms in the androgen and type 11 5a-reductase genes in prostate anlargement J Urol 2001;166:1560-4.
27.Bousema JT,Bussemakers MJ,van Houwelingen KP,Debruyne FM,Verbeek AL.et al.Polymorphisms in the
28.Roberts RO,Bergstralh EJ,Cunningham JM,Hebbring SJ,Thibodeau SN,et al.Androgen receptor gene polymorphisms and increased risk ao urologic measures of benin prostatic hyperplasi.Am J Epidemiol 2004; 159(3): 269-76.
29.Xue W,Irvine RA,Yu MC,Ross RK,Coetze GA,et al.Susceptibility to prostate cancer:interaction beetwen genotypes at the androgen receptor and prostate-specific antigen loci.Cancer Res 2000;60:839-41.
30.Gaston KE,Kim D, Singh S,Ford H,Mohler JL.Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer.J Urol 2003;170:90-3.
31.Yu H. Bharaj B.Vassilikos EJ,Giai M,Diamandis EP.Shorter CAG repeat length in the androgen receptor gene is associated with more agressive forms of breast cancer.Breast Cancer Res Treat 2000;59:153-61.
32.Visvanathan K,Helzlsouer KJ,Boorman DW,Strickland PT,Hoffman SC,et al.Association among an ornithine decarboxylase polymorphisn,androgen receptor gene(CAG)repeat lenght and prostate cancer risk.J Urol 2004; 171(2):652-5.
33.Balic I,Graham ST,Troyer DA,Higgins BA,Pollock BH,et al.Androgen receptor length polymorphism associated with prostate cancer risk in hispanic men.J Urol 2002;168(5):2245-8.
34.Zhao XY,Peehl DM,Navone NM,Feldman D.I alpha,25 dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androge-independent mechanisms.Endocrinology 2000;141:2548-56.
35.Price DK,Franks ME,Figg WD.Genetic variations in the vitamin D receptor, androgen receptor and enzymes that regulate androgen metabolism.J Urol 2004;171(2 Suppl.): 45-9.
36.Gsur A,Madersbacher S.Haidinger G,Schatzl G,Marberger M,et al Vitamin D receptor gene polymorphism and prostate cancer risk.Prostate 2002:51(1):30-4.
37.Paiss T,Gschwend J,Autenrieth M,Correa-Cerro L,Haussler J,et al.Vitamin D receptor polymorphisms and prostate cancer risk in an European population.J Urol 1999;,161(4s):56.